INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo CETIZAL  5

For full prescribing information please refer to the package insert.

SCHEDULING STATUS:
S2

PROPRIETARY NAME
(and dosage form):

CETIZAL  5
Tablets

COMPOSITION:
Each film coated tablet contains 5 mg
levocetirizine hydrochloride.

INDICATIONS:
CetizalTM5 is indicated for the relief of symptoms associated with the following allergic conditions in adults:
- Seasonal allergic rhinitis.
- Perennial allergic rhinitis.
- Chronic idiopathic urticaria

IDENTIFICATION
White, film coated, scored, round biconvex tablets, debossed with ‘161’on one side and ‘H’on the other side.

PRESENTATION:
10s and 30s

REGISTRATION NUMBER:
46/5.7.1/0329

APPLICANT:
Ranbaxy (SA) (Pty) Ltd,
Ground Floor,
Tugela House,
Riverside Office Park,
1303 Heuwel Avenue,
Centurion, 0046.
Phone +27 12 643 2000; Fax: +27 12 643-2001.

Should you have any queries please contact your Sun Pharma representative

Launch Date 10
th May 2016

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2017